Skip to main content

Prestige Consumer Healthcare Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

PBH$43.67+1.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. OTHER INFORMATION

Rule 10b5-1 Trading Arrangements

The following is a summary of the material terms of the contracts, instructions or written plans for the purchase or sale of the Company's securities adopted orterminated by our officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) or directors during the three months ended June 30, 2026:

Name and PositionDate of SignatureEffective DateActionSatisfies Affirmative Defense under Rule 10b5-1(c)Expiration DateTotal Ordinary Shares to be Sold
Jeffrey ZerilloJune 11, 2026October 1, 2026AdoptionXAugust 27, 202710,444
Senior Vice President Operations

Submission of Matters to a Vote of Security Holders.

The 2026 Annual Meeting of Stockholders of the Company was held on August 4, 2026. The stockholders of the Company voted upon three proposals at the Annual Meeting, with the following results:

Director NomineeForWithheldBroker Non-Votes
Ronald M. Lombardi45,785,8721,716,653564,694
John E. Byom43,227,9072,274,618564,694
Celeste A. Clark43,610,9941,891,531564,694
James C. D'Arecca45,123,407379,118564,694
John F. Kelly43,800,8231,701,702564,694
Dawn M. Zier43,959,2051,543,320564,694
ForAgainstAbstentionsBroker Non-Votes
43,638,5311,852,81611,178564,694
ForAgainstAbstentions
44,469,5231,590,9546,742
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.